Mathieson et al. identified that specific CAF subpopulations expressing FAP and podoplanin in NSCLC serve as predictors of poor clinical outcomes, highlighting the importance of characterizing CAF subtypes in NSCLC [64]. The gene discussed is FAP; the disease is non-small cell lung carcinoma.